Biotech R & D spending continues to rise
Nature Reviews Drug Discovery 16, 447 (2017).
doi:10.1038/nrd.2017.130
Author: Asher Mullard
Biotech R&D spending hit US$45.7 billion in 2016, up 12% from 2015, found an annual analysis of the sector by consulting firm EY (see Fig. 1). This was the seventh consecutive year that these firms increased their cumulative R&D spending, and the second consecutive
Source: Nature Reviews Drug Discovery - Category: Drugs & Pharmacology Authors: Asher Mullard Tags: News and Analysis Source Type: research
More News: Biotechnology | Drugs & Pharmacology